🇺🇸 Tetanus Toxoid Adsorbed Vaccine in United States
456 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 456
Most-reported reactions
- Drug Hypersensitivity — 70 reports (15.35%)
- Fatigue — 52 reports (11.4%)
- Arthralgia — 50 reports (10.96%)
- Malaise — 49 reports (10.75%)
- Pain — 48 reports (10.53%)
- Pyrexia — 43 reports (9.43%)
- Nausea — 38 reports (8.33%)
- Dyspnoea — 36 reports (7.89%)
- Drug Ineffective — 35 reports (7.68%)
- Foetal Exposure During Pregnancy — 35 reports (7.68%)
Other Immunology approved in United States
Frequently asked questions
Is Tetanus Toxoid Adsorbed Vaccine approved in United States?
Tetanus Toxoid Adsorbed Vaccine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Tetanus Toxoid Adsorbed Vaccine in United States?
Genentech, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.